PGIM Ultra Short News

Fonds
WKN:  ISIN:  US69344A1079 US-Symbol:  PULS
42,527 €
+0,015 $
+0,03%
42,527 € 21:57:54 Uhr
Depot/Watchlist
Ertragsverwendung
-
Lfd. Kosten
-
Fondsgröße
-  
Währung
FWW Fundstars
keine Bewertung

PGIM Ultra Short News

02.02.26 - PR Newswire
Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center
Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center PR Newswire
03.11.25 - PR Newswire
Pulsenmore Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S.
Pulsenmore Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S. PR Newswire
03.11.25 - PR Newswire
Pulsenmore Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S.
Pulsenmore Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S. PR Newswire
30.10.24 - PR Newswire
Pulsenmore Expands Partnership with Clalit Health Services to Deliver 25,000 Home Ultrasound Devices for Remote Prenatal Care
Pulsenmore Expands Partnership with Clalit Health Services to Deliver 25,000 Home Ultrasound Devices for Remote Prenatal Care PR Newswire
03.06.24 - PR Newswire
Pulsenmore Appoints Len Farris as Chief Commercial Officer to Lead Global Expansion of Breakthrough Home Ultrasound Technology
Pulsenmore Appoints Len Farris as Chief Commercial Officer to Lead Global Expansion of Breakthrough Home Ultrasound Technology PR Newswire
13.03.24 - PR Newswire
Pulsenmore is expanding the application of its home ultrasound solution for pregnant women: a clinical trial with Michigan Medicine will focus on the remote assessment of the fetal biophysical profile
Pulsenmore is expanding the application of its home ultrasound solution for pregnant women: a clinical trial with Michigan Medicine will focus on the remote assessment of the fetal ...
10.01.24 - PR Newswire
Pulsenmore Receives Brazilian ANVISA Approval for Its Prenatal Home Ultrasound Solution
Pulsenmore Receives Brazilian ANVISA Approval for Its Prenatal Home Ultrasound Solution PR Newswire
19.04.23 - PR Newswire
Pulsenmore, Entwickler von Heim-Ultraschallgeräten, baut seine europäischen Aktivitäten aus und ernennt einen General Manager
Pulsenmore, Entwickler von Heim-​Ultraschallgeräten, baut seine europäischen Aktivitäten aus und ernennt einen General Manager PR Newswire
19.04.23 - PR Newswire
Home Ultrasound Developer Pulsenmore Establishes European Operations and Appoints General Manager
Home Ultrasound Developer Pulsenmore Establishes European Operations and Appoints General Manager PR Newswire

Newssuche

Videos

newspaper
20.04.26 -2,08%
Technical Trading: GBP Long im Trend
GBP/USD Long Typ: Open End Turbo WKN: VV7A4S Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »